The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index; none of the 162 sources its claims cite is checked for support yet.
Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline
Open accessAbstract
Objectives: To improve awareness and recognition of chronic bacterial prostatitis ( CBP ) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) among non‐specialists and patients. To provide guidance to healthcare professionals treating patients with CBP and CP / CPPS , in both non‐specialist and specialist settings. To promote efficient referral of care between non‐specialists and specialists and the involvement of the multidisciplinary team ( MDT ). Patients and Methods: The guideline population were men with CBP or CP / CPPS (persistent or recurrent symptoms and no other urogenital pathology for ≥3 of the previous 6 months). Consensus recommendations for the guidelines were based on a search to identify literature on the diagnosis and management of CBP and CP / CPPS (published between 1999 and February 2014). A Delphi panel process was used where high‐quality, published evidence was lacking. Results: CBP and CP / CPPS can present with a wide range of clinical manifestations. The four main symptom domains are urogenital pain, lower urinary tract symptoms ( LUTS – voiding or storage symptoms), psychological issues and sexual dysfunction. Patients should be managed according to their individual symptom pattern. Options for first‐line treatment include antibiotics, α‐adrenergic antagonists (if voiding LUTS are present) and simple analgesics. Repeated use of antibiotics, such as quinolones, should be avoided if there is no obvious symptomatic benefit from infection control or cultures do not support an infectious cause. Early use of treatments targeting neuropathic pain and/or referral to specialist services should be considered for patients who do not respond to initial measures. An MDT approach (urologists, pain specialists, nurse specialists, specialist physiotherapists, general practitioners, cognitive behavioural therapists/psychologists, and sexual health specialists) is recommended. Patients should be fully informed about the possible underlying causes and treatment options, including an explanation of the chronic pain cycle. Conclusion: Chronic prostatitis can present with a wide variety of signs and symptoms. Identification of individual symptom patterns and a symptom‐based treatment approach are recommended. Further research is required to evaluate management options for CBP and CP / CPPS .
Overview
CoChat Summary
TL;DR
This consensus guideline from the Prostatitis Expert Reference Group provides symptom-based diagnosis and management recommendations for chronic bacterial prostatitis (CBP) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). It recommends individualized care across four symptom domains, cautious antibiotic use, early consideration of neuropathic pain treatment/referral, and a multidisciplinary approach.
Key findings
- CBP and CP/CPPS should be managed by individual symptom pattern across four main domains: urogenital pain, lower urinary tract symptoms (LUTS), psychological issues, and sexual dysfunction; no single management pathway suits all patients.
- Reported symptom burdens include perineal pain as the most prevalent pain localization (63%), irritable bowel syndrome in 22–31%, ≥1 LUTS in 39–68%, and in CP/CPPS cohort studies (n = 130–1,800) total/partial erectile dysfunction in 15–55% and overall self-reported sexual dysfunction in 46–92%.
- First-line options include antibiotics, α-adrenergic antagonists if voiding LUTS are present, and simple analgesics; repeated quinolone use should be avoided if there is no obvious symptomatic benefit or cultures do not support infection, and early neuropathic pain treatment/referral plus multidisciplinary team care is recommended for non-responders.
- In CBP, microbiological eradication rates were 40–77% for ciprofloxacin, 75% for levofloxacin, 80% for azithromycin, 77% for doxycycline, 80% for clarithromycin, and 62–77% for azithromycin + ciprofloxacin; most α-blocker RCTs showed positive results, but two larger placebo-controlled trials of tamsulosin (n = 196) and alfuzosin (n = 272) failed to show significant total NIH-CPSI differences.
Methods
- Consensus guideline developed by the Prostatitis Expert Reference Group (PERG); guideline population were men with CBP or CP/CPPS, defined as persistent or recurrent symptoms and no other urogenital pathology for ≥3 of the previous 6 months.
- Literature search on diagnosis and management of CBP and CP/CPPS published between 1999 and 7 February 2014, primarily Medline via PubMed, plus Cochrane Library and guideline groups including NICE and EAU; references graded using Oxford Centre for Evidence-based Medicine Levels of Evidence.
- A web-based Delphi panel process was used where high-quality published evidence was lacking: three questionnaire rounds via Survey Monkey, circulated to 58 participants, with 35 (60%), 29 (50%), and 26 (45%) responding to rounds 1–3; consensus was defined as agreement of ≥70% of respondents, with PERG/technical input where consensus was not achieved.
Limitations
- Paper-stated: there are limited published randomised controlled trials in CBP and CP/CPPS; the Delphi panel was used where high-quality evidence was lacking; many recommendations are Level 5; further research is required; there is no “gold standard” for definitive CP/CPPS diagnosis; evidence is scarce for pain pharmacotherapy, surgical interventions, and CBT/psychotherapy; many studies are small, lack placebo/control arms, or are heterogeneous.
- Evident from the text: this is a consensus guideline rather than a systematic review or meta-analysis, and the Delphi panel had declining response rates (60% to 45%) with a ≥70% respondent consensus threshold, so several recommendations rest on expert opinion.
- Evident from the text: some cited evidence is indirect or limited, such as the REDUCE dutasteride study not being primarily designed as a CP/CPPS treatment trial, and several physiotherapy, acupuncture, phytotherapy, and surgical findings coming from small pilot or proof-of-principle studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
0 Valid · 0 Not valid · 89 Not checked · 29 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The evidence on surgical management techniques such as prostatectomy, transurethral resection of the prostate (TURP), transrectal high‐intensity focused ultrasound (HIFU), transurethral needle ablation (TUNA) of the prostate, and transurethral microwave thermotherapy in CP/CPPS is very limited (Table 5).”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Recommendations (All Level 5)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While it is recognised that psychosocial symptoms may be part of CBP and CP/CPPS 29, 41, 42, 43, no evidence from RCTs or comparative studies is available to support the use of psychological treatment or CBT in these settings.”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Recommendations (All Level 5)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Phytotherapy has a modest beneficial effect on symptom improvement in CBP and CP/CPPS and may be considered as a treatment option in treatment‐refractory patients (Level 2).”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Recommendations (All Level 5)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Several studies of acupuncture have provided positive results (Table 5).”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Recommendations (All Level 5)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Despite having a significant negative impact on patients' quality of life (QoL) 4 and presenting diagnostic and therapeutic challenges for physicians, CBP and CP/CPPS have received relatively little attention in the literature, in comparison with other urological conditions 2.”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Introduction
What the sources say
- Not checked yetcites [2] Pavone‐Macaluso M. Chronic prostatitis syndrome: a common, but poorly understood condition. Part I. EAU‐EBU Update Ser 2007; 5: 1– 15
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
64 more claims
Create a free account to see all 118 claims and to verify the 128 references still open.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 35
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Treatment Strategies
“Only two RCTs were identified for NSAIDs, one of which evaluated rofecoxib 75 (now withdrawn from the market). The second RCT evaluated celecoxib in patients with CP/CPPS”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Treatment Strategies
“An RCT (n = 50) evaluated ibuprofen vs a terpenic mixture (Rowatinex®) in CP/CPPS; ibuprofen (n = 25) was associated with a significant improvement from baseline in total, pain and QoL NIH‐CPSI scores after 6 weeks' treatment, but was outperformed by the terpene mixture 77.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Treatment Strategies
“Most (eight) showed positive results, with significant differences vs placebo in NIH‐CPSI total, urinary symptom, pain, and/or QoL scores 54, 55, 56, 57, 59, 60, or in scores using other validated symptom scoring tools 58, 61.”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Treatment Strategies
“Notably, two of the larger, placebo‐controlled trials that evaluated tamsulosin (n = 196) 53 and alfuzosin (n = 272) 57 failed to show any significant difference in total NIH‐CPSI scores, the only outcome achieving statistical significance being the score for ejaculation on the Male Sexual Health Questionnaire (P = 0.04) in the alfuzosin trial.”
Citations
Cites
The Delphi Technique: Making Sense of Consensus
Hsu, C.-C., & Sandford, B. A. (2007) · University of Massachusetts Amherst · doi:10.7275/pdz9-th90 · Cited by 4,500
LITWIN, M. S., McNAUGHTON-COLLINS, M., FOWLER, F. J., NICKEL, J. C., CALHOUN, E. A., PONTARI, M. A., ALEXANDER, R. B., FARRAR, J. T., & O'LEARY, M. P. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68562-x · Cited by 947
Guidelines on Urological Infections
Grabe, M. J., Bartoletti, R., Cai, T., Köves, B., Peter Tenke, A., Wagenlehner, F., & Wullt, B. (2009) · Cited by 759
Shoskes, D. A., Zeitlin, S. I., Shahed, A., & Rajfer, J. (1999) · Urology · doi:10.1016/s0090-4295(99)00358-1 · Cited by 408
Krieger, J. N., Lee, S. W. H., Jeon, J., Cheah, P. Y., Liong, M. L., & Riley, D. E. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.08.028 · Cited by 389
the Chronic Prostatitis Collaborative Research Network, McNaughton Collins, M., Pontari, M. A., O’Leary, M. P., Calhoun, E. A., Santanna, J., Landis, J. R., Kusek, J. W., & Litwin, M. S. (2001) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2001.01223.x · Cited by 281
Anothaisintawee, T. (2011) · JAMA · doi:10.1001/jama.2010.1913 · Cited by 278
Alexander, R. B., Propert, K. J., Schaeffer, A. J., Landis, J. R., Nickel, J. C., O'Leary, M. P., Pontari, M. A., McNaughton-Collins, M., Shoskes, D. A., Comiter, C. V., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-8-200410190-00005 · Cited by 262
ANDERSON, R. U., WISE, D., SAWYER, T., & CHAN, C. (2005) · Journal of Urology · doi:10.1097/01.ju.0000161609.31185.d5 · Cited by 210
Nickel, J. C., Downey, J., Clark, J. M., Casey, R. W., Pommerville, P. J., Barkin, J., Steinhoff, G., Brock, G. B., Patrick, A., Flax, S., et al. (2003) · Urology · doi:10.1016/s0090-4295(03)00583-1 · Cited by 206
Research works printed but not linked: 2
- Nyberg LM, 1999, Textbook of Prostatitis, 28
- University of Oxford Centre for Evidence Based Medicine.OCEBM Levels of Evidence System. Available at:http://www.cebm.net/index.aspx?o=5653. Accessed June 2014
Cited by
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gonzalez, M. D., Harrington, A., Jerris, R. C., Kehl, S. C., Leal, S. M., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae104 · Cited by 376
Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome
Franco, J. V. A., Turk, T., Jung, J. H., Xiao, Y., Iakhno, S., Garrote, V., & Vietto, V. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012551.pub3 · Cited by 163
Efficacy of Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Randomized Trial
Sun, Y., Liu, Y., Liu, B., Zhou, K., Yue, Z., Zhang, W., Fu, W., Yang, J., Li, N., He, L., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m21-1814 · Cited by 128
Multidisciplinary approach to prostatitis
Magri, V., Boltri, M., Cai, T., Colombo, R., Cuzzocrea, S., Visschere, P. D., Giuberti, R., Granatieri, C., Latino, M. A., Larganà, G., et al. (2019) · Archivio Italiano di Urologia e Andrologia · doi:10.4081/aiua.2018.4.227 · Cited by 127
Urinary Tract Infections in Older Men
Schaeffer, A. J., & Nicolle, L. E. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1503950 · Cited by 127
Zhang, J., Liang, C. Y., Shang, X., & Li, H. (2020) · American Journal of Men s Health · doi:10.1177/1557988320903200 · Cited by 117
Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome
Franco, J. V. A., Turk, T., Jung, J. H., Xiao, Y., Iakhno, S., Tirapegui, F. I., Garrote, V., & Vietto, V. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012552.pub2 · Cited by 113
Franco, J. V. A., Turk, T., Jung, J. H., Xiao, Y., Iakhno, S., Garrote, V., & Vietto, V. (2018) · British Journal of Urology · doi:10.1111/bju.14492 · Cited by 109
Paulis, G. (2018) · Research and Reports in Urology · doi:10.2147/rru.s170400 · Cited by 107
Peña, V. N., Engel, N., Gabrielson, A. T., Rabinowitz, M. J., & Herati, A. S. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00890-2 · Cited by 102
Zhao, Q., Yang, F., Meng, L., Chen, D., Wang, M., Lu, X., Chen, D., Jiang, Y., & Xing, N. (2019) · Andrology · doi:10.1111/andr.12747 · Cited by 97
Bharucha, A. E., & Lee, T. H. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.08.011 · Cited by 94
Calogero, A. E., Condorelli, R. A., Russo, G. I., & Vignera, S. L. (2017) · BioMed Research International · doi:10.1155/2017/4650182 · Cited by 89
Franco, J. V. A., Turk, T., Jung, J. H., Xiao, Y., Iakhno, S., Tirapegui, F. I., Garrote, V., & Vietto, V. (2020) · British Journal of Urology · doi:10.1111/bju.14988 · Cited by 82
Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome
Franco, J. V. A., Turk, T., Jung, J. H., Xiao, Y., Iakhno, S., Garrote, V., & Vietto, V. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012551.pub2 · Cited by 75
Systematic Review of Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Qin, Z., Wu, J., Zhou, J. W., & Liu, Z. (2016) · Medicine · doi:10.1097/md.0000000000003095 · Cited by 73
Johri, A. V., Johri, P., Hoyle, N. S., Pipia, L., Nadareishvili, L., & Nizharadze, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.692614 · Cited by 70
Hu, Y., Niu, X., Wang, G., Huang, J., Liu, M., & Peng, B. (2016) · Andrology · doi:10.1111/andr.12273 · Cited by 69
Gill, B. C., & Shoskes, D. A. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000222 · Cited by 66
Ye, Y., Zhong, W., Luo, R., Wen, H., Ma, Z., Qi, S., Han, X., Nie, W., Chang, D., Xu, R., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02282-7 · Cited by 65
Chronic Prostatitis/Chronic Pain Pelvic Syndrome and Male Infertility
Graziani, A., Grande, G., Martin, M., Ferraioli, G., Colonnello, E., Iafrate, M., Moro, F. D., & Ferlin, A. (2023) · Life · doi:10.3390/life13081700 · Cited by 63
Qin, Z., Zang, Z., Zhou, K., Wu, J., Zhou, J. W., Kwong, J. S., & Liu, Z. (2018) · The Journal of Urology · doi:10.1016/j.juro.2018.05.001 · Cited by 63
Morgia, G., Russo, G. I., Urzì, D., Privitera, S., Castelli, T., Favilla, V., & Cimino, S. (2017) · Archivio Italiano di Urologia e Andrologia · doi:10.4081/aiua.2017.2.110 · Cited by 62
Pharmacological Interventions for Bacterial Prostatitis
Xiong, S., Liu, X., Deng, W., Zhou, Z., Li, Y., Tu, Y., Chen, L., Wang, G., & Fu, B. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00504 · Cited by 62
Common Questions About Chronic Prostatitis.
Holt, J. D., Garrett, W. A., McCurry, T. K., & Teichman, J. M. H. (2016) · PubMed · Cited by 58
Oral fosfomycin for the treatment of chronic bacterial prostatitis
Karaiskos, I., Galani, L., Sakka, V., Gkoufa, A., Sopilidis, O., Chalikopoulos, D., Alivizatos, G. J., & Giamarellou, E. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz015 · Cited by 56
Urinary Tract Infections in Older Men
Etienne, M., Galpérine, T., & Caron, F. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1603508 · Cited by 56
Jeon, S. H., Zhu, G., Kwon, E. B., Lee, K. W., Cho, H. J., Ha, U., Hong, S., Lee, J. Y., Bae, W. J., & Kim, S. W. (2019) · The Prostate · doi:10.1002/pros.23880 · Cited by 55
Management of Chronic Bacterial Prostatitis
Su, Z. T., Zenilman, J. M., Sfanos, K. S., & Herati, A. S. (2020) · Current Urology Reports · doi:10.1007/s11934-020-00978-z · Cited by 55
Zhan, C., Chen, J., Chen, J., Zhang, L., Liu, Y., Du, H., Wang, H., Zheng, M., Yu, Z., Chen, X., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902910rrr · Cited by 52
Borgert, B. J., Wallen, E. M., & Pham, M. N. (2025) · JAMA · doi:10.1001/jama.2025.11499 · Cited by 50
Male CP/CPPS: where do we stand?
Doiron, R. C., Shoskes, D. A., & Nickel, J. C. (2019) · World Journal of Urology · doi:10.1007/s00345-019-02718-6 · Cited by 50
Antibiotic Treatment of Infections Caused by AmpC-Producing Enterobacterales
Tebano, G., Zaghi, I., Cricca, M., & Cristini, F. (2024) · Pharmacy · doi:10.3390/pharmacy12050142 · Cited by 49
Liu, B., Wang, Y.-T., & Chen, S. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1403-z · Cited by 46
How I manage bacterial prostatitis
Lam, J. C., Lang, R., & Stokes, W. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.05.035 · Cited by 45
Qin, Z., Wu, J., Tian, J., Zhou, J., Liu, Y., & Liu, Z. (2016) · Scientific Reports · doi:10.1038/srep35737 · Cited by 41
Chang, S., Hsu, C., Hsu, C., Yang, S. S., & Chang, S. (2016) · Neurourology and Urodynamics · doi:10.1002/nau.22958 · Cited by 39
Evolving Role of Silodosin for the Treatment of Urological Disorders – A Narrative Review
Jindan, L., Wang, X., & Li-ping, X. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s373659 · Cited by 37
Gao, Y., Liu, K., Zhang, Y., Sun, Z., Song, B., Wang, Y., Zhang, B., Chen, X., Hu, D., Wen, J., et al. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.120668 · Cited by 37
Diagnosis and treatment of bacterial prostatitis
Zorman, J. V., Matičič, M., Jeverica, S., & Smrkolj, T. (2015) · Acta Dermatovenerologica Alpina Pannonica et Adriatica · doi:10.15570/actaapa.2015.8 · Cited by 36
Jhang, J., & Kuo, H. (2015) · Toxins · doi:10.3390/toxins7062232 · Cited by 36
Phage Therapy in Prostatitis: Recent Prospects
Górski, A., Jończyk‐Matysiak, E., Łusiak-Szelachowska, M., Międzybrodzki, R., Weber‐Dąbrowska, B., Borysowski, J., Letkiewicz, S., Bagińska, N., & Sfanos, K. S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01434 · Cited by 33
Screening for chronic prostatitis pathogens using high‐throughput next‐generation sequencing
Wu, Y., Jiang, H., Tan, M., & Lu, X. (2020) · The Prostate · doi:10.1002/pros.23971 · Cited by 32
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): look to the future
Cai, T., Alidjanov, J. F., Palagin, I. S., Medina‐Polo, J., Nickel, J. C., & Wagenlehner, F. (2023) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-023-00645-7 · Cited by 31
Kong, X., Hu, W., Dong, Z., Tian, J., Wang, Y., Jin, C., Liang, C. Y., Hao, Z., & Wang, Z. (2022) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-022-00571-0 · Cited by 30
Chronic primary pelvic pain syndrome in men—differential diagnostic evaluation and treatment
Franz, J., Kieselbach, K., Lahmann, C., Gratzke, C., & Miernik, A. J. (2023) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2023.0036 · Cited by 30
Qin, Z., Wu, J., Xu, C., Sang, X., Li, X., Huang, G., & Liu, Z. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2018.06.44 · Cited by 30
Zhang, Z., Zhang, D., Yu, X., & Ma, Y. (2018) · American Journal of Men s Health · doi:10.1177/1557988318814663 · Cited by 30
Santharam, M. A., Khan, F. U., Naveed, M., Ali, U., Ahsan, M. Z., Khongorzul, P., Shoaib, R. M., & Ihsan, A. U. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172429 · Cited by 30
The Hypermethylation of Foxp3 Promoter Impairs the Function of Treg Cells in EAP
Chen, J., Zhan, C., Zhang, L., Zhang, L., Liu, Y., Zhang, Y., Du, H., Liang, C. Y., & Chen, X. (2019) · Inflammation · doi:10.1007/s10753-019-01030-0 · Cited by 29
Chou, A., Welch, E., Hunter, A. S., & Trautner, B. W. (2022) · Drugs · doi:10.1007/s40265-022-01676-5 · Cited by 29
Chronic prostatitis (chronic pelvic pain syndrome)
Healy, R., Thorne, C., & Manjunath, A. (2023) · BMJ · doi:10.1136/bmj-2023-073908 · Cited by 28
Du, H., Chen, X., Zhang, L., Liu, Y., Zhan, C., Chen, J., Wang, H. J., Yu, Z., & Liang, C. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00723-2 · Cited by 28
Zhang, W., Fang, Y., Shi, M., Zhang, M., Chen, Y., & Zhou, T. T. (2021) · Translational Andrology and Urology · doi:10.21037/tau-20-913 · Cited by 28
Contemporary Management of Chronic Prostatitis
Khattak, A. S., Raison, N. T. J., Hawazie, A., Khan, A., Brunckhorst, O., & Ahmed, K. (2021) · Cureus · doi:10.7759/cureus.20243 · Cited by 28
Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome
Franco, J. V. A., Tirapegui, F. I., Turk, T., Garrote, V., & Vietto, V. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012552 · Cited by 27
Zhang, F., Tong, M., Feng, R., Jin, C., Zhang, S., Meng, J., Zhang, M., & Liang, C. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112891 · Cited by 26
Kurita, M., Yamaguchi, H., Okamoto, K., Kotera, T., & Oka, M. (2018) · The Prostate · doi:10.1002/pros.23690 · Cited by 26
Morozov, A., Bazarkin, A., Babaevskaya, D., Taratkin, M. S., Козлов, В. В., Suvorov, А. Y., Spivak, L., McFarland, J., Russo, G. I., Enikeev, D. V., et al. (2022) · The Prostate · doi:10.1002/pros.24311 · Cited by 25
Post orgasmic illness syndrome: what do we know till now?
Abdessater, M., Elias, S., Mikhael, E., Alhammadi, A., & Beley, S. (2019) · Basic and Clinical Andrology · doi:10.1186/s12610-019-0093-7 · Cited by 25
Doiron, R. C., Tripp, D. A., Tolls, V., & Nickel, J. C. (2018) · Canadian Urological Association Journal · doi:10.5489/cuaj.4876 · Cited by 24
Intraprostatic Reflux of Urine Induces Inflammation in a Rat
Funahashi, Y., Majima, T., Matsukawa, Y., Yamamoto, T., Yoshida, M., & Gotoh, M. (2016) · The Prostate · doi:10.1002/pros.23257 · Cited by 24
Using the UPOINT system to manage men with chronic pelvic pain syndrome
Bryk, D. J., & Shoskes, D. A. (2021) · Arab Journal of Urology · doi:10.1080/2090598x.2021.1955546 · Cited by 24
Tawfik, A. M., Radwan, M. H., Abdulmonem, M., Abo-Elenen, M., Elgamal, S., & Aboufarha, M. O. (2022) · World Journal of Urology · doi:10.1007/s00345-022-04074-4 · Cited by 23
Chen, J., Feng, R., Gong, B.-B., Wu, W., Dai, B., Tan, R., Xu, W.-L., Tong, M., Wang, X., Xiao, Y., et al. (2025) · Military Medical Research · doi:10.1186/s40779-025-00607-1 · Cited by 22
Trinchieri, A., Abdelrahman, K. M., Bhatti, K. H., Bello, J. O., Das, K., Gatsev, O., Gergova, I., Magri, V., Mourmouras, N., Mourmouris, P., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11081333 · Cited by 22
Zhang, J., Chen, J., Jiang, Q., Feng, R., Zhao, X., Li, H., Yang, C., & Hua, X. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s408111 · Cited by 22
Hua, X., Zhang, J., Chen, J., Feng, R., Zhang, L., Chen, X., Jiang, Q., Yang, C., & Liang, C. Y. (2024) · The Prostate · doi:10.1002/pros.24683 · Cited by 22
Effect of thermobalancing therapy on chronic prostatitis and chronic pelvic pain syndrome
Allen, S. M., & Aghajanyan, I. G. (2016) · Journal of Clinical Urology · doi:10.1177/2051415816671036 · Cited by 22
Cheng, Y., Cao, Y., Ihsan, A. U., Khan, F. U., Li, X., Xie, D., Cui, X., Wang, W., Liu, Z., Li, C., et al. (2019) · Inflammation · doi:10.1007/s10753-019-00968-5 · Cited by 22
Chen, J., Zhang, H. S., Niu, D., Li, H., Wei, K., Zhang, L., Yin, S., Liu, L., Zhang, X., Zhang, M., et al. (2020) · BMC Urology · doi:10.1186/s12894-020-00729-9 · Cited by 22
Wang, H., Zhang, J., Ma, D., & Zhao, Z. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s417066 · Cited by 21
Therapeutic Applications of Functional Nanomaterials for Prostatitis
Liu, C., Chen, Z., Ye, Z.-Y., He, D., Dang, Y., Li, Z.-W., Wang, L., Ren, M., Fan, Z., & Liu, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.685465 · Cited by 21
Chronische Prostatitis/chronisches Beckenschmerzsyndrom
Magistro, G., Stief, C. G., & Wagenlehner, F. (2020) · Der Urologe · doi:10.1007/s00120-020-01226-5 · Cited by 21
Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction
Jhang, J., & Kuo, H. (2018) · Toxins · doi:10.3390/toxins10070260 · Cited by 20
Li, X., Zhang, X., Liao, Z., Tang, Z., & Li, D. (2020) · Asian Journal of Andrology · doi:10.4103/aja.aja_71_20 · Cited by 20
Sevim, M., Alkış, O., Kartal, İ. G., Kazan, H. Ö., İvelik, H. İ., Aras, B., & Kabay, Ş. (2023) · The Prostate · doi:10.1002/pros.24513 · Cited by 19
The role of red ginseng in men’s reproductive health: a literature review
Wang, H., Zhang, J., Ma, D., Zhao, Z., Yan, B., & Wang, F. (2023) · Basic and Clinical Andrology · doi:10.1186/s12610-023-00203-0 · Cited by 18
Research trends of prostatitis over past 20 years: A bibliometric analysis
Chen, Q., Feng, J., Liu, Z., An, D., Li, Y., Zhou, S., & Weng, Z. (2021) · Andrologia · doi:10.1111/and.14206 · Cited by 18
Chronische Prostatitis/chronisches Beckenschmerzsyndrom
Magistro, G., Wagenlehner, F., & Pilatz, A. M. E. (2023) · Die Urologie · doi:10.1007/s00120-023-02089-2 · Cited by 18
Inflammation of the male reproductive system: clinical aspects and mechanisms
Bao, B., Wen, H., Wang, F., Han, D., & Liu, B. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1547020 · Cited by 17
Stevens, R. H., Zhang, H., Kajsík, M., Płoski, R., Rydzanicz, M., Sabaka, P., & Šutovský, S. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1238147 · Cited by 17
Relation between histological prostatitis and lower urinary tract symptoms and erectile function
Mizuno, T., Hiramatsu, I., Aoki, Y., Shimoyama, H., Nozaki, T., Shirai, M., Lü, Y., Horie, S., & Tsujimura, A. (2017) · Prostate International · doi:10.1016/j.prnil.2017.04.001 · Cited by 17
Recent advances in managing chronic prostatitis/chronic pelvic pain syndrome
Sandhu, J. S., & Tu, H. Y. V. (2017) · F1000Research · doi:10.12688/f1000research.10558.1 · Cited by 17
Xue, Y., Duan, Y., Gong, X., Zheng, W., & Li, Y. (2019) · Medicine · doi:10.1097/md.0000000000016136 · Cited by 17
Matsukawa, Y., Naito, Y., Funahashi, Y., Ishida, S., Fujita, T., Tochigi, K., Kato, M., & Gotoh, M. (2020) · Neurourology and Urodynamics · doi:10.1002/nau.24454 · Cited by 17
The presence of Chlamydia trachomatis infection in men with chronic prostatitis
Bielecki, R., Ostaszewska-Puchalska, I., Zdrodowska-Stefanow, B., Baltaziak, M., Skawrońska, M., & Sokołowska, M. (2020) · Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication · doi:10.5173/ceju.2020.0040 · Cited by 17
Jin, B., Ju, J.-Y., Nugroho, A., Lee, M., & An, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111197 · Cited by 17
Modern opportunities for the treatment of chronic prostatitis
Bozhedomov, V. A. (2016) · Andrology and Genital Surgery · doi:10.17650/2070-9781-2016-17-3-10-22 · Cited by 17
Yang, S., Lu, J., Chen, X., Liang, C. Y., Luo, P., Qin, C., & Zhang, J. (2018) · Inflammation · doi:10.1007/s10753-018-0786-7 · Cited by 17
Krakhotkin, D. V., Chernylovskyi, V. A., Bakurov, E. E., & Sperl, J. (2019) · Therapeutic Advances in Urology · doi:10.1177/1756287219857271 · Cited by 17
Yin, L., Tang, Y., Pan, A., Yang, L., Zhu, X., & Liu, Y. (2019) · Medicine · doi:10.1097/md.0000000000016848 · Cited by 17
Dashdondov, O., Wazir, J., Sukhbaatar, G., Mikrani, R., Dorjsuren, B., Aktar, N., & Zhou, X. (2021) · International Urology and Nephrology · doi:10.1007/s11255-021-02868-w · Cited by 17
Niu, D., Yue, S.-Y., Wang, X., Li, W.-Y., Zhang, L., Du, H., & Liang, C.-Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111682 · Cited by 16
Zhang, K.-Y., Zhang, Y., Hong, S., Cao, Y.-T., & Liu, C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280821 · Cited by 16
Xu, Y., Zhang, L., Shen, Y., Yao, H., Yong, S., & You, Y. (2020) · Medicine · doi:10.1097/md.0000000000022151 · Cited by 16
Dun, R.-L., Tsai, J., Hu, X., Mao, J.-M., Zhu, W.-J., Qi, G.-C., & Peng, Y. (2021) · Health and Quality of Life Outcomes · doi:10.1186/s12955-021-01796-8 · Cited by 15
Feng, R., Tong, M., Zhao, X., Yu, W., Li, H., Wang, Z., Chen, J., & Yang, C. H. (2024) · Molecular Immunology · doi:10.1016/j.molimm.2024.03.002 · Cited by 15
Fácio, F. N., Colonnello, E., Alzweri, L. M., Citrín, E., Dubinskaya, A., Falsetta, M., Fregonesi, A., Kellogg‐Spadt, S., Lopes, L. S., & Jannini, E. A. (2025) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeaf021 · Cited by 15
Microbial etiology of bacterial chronic prostatitis: systematic review
Mendoza-Rodríguez, R., Hernández‐Chico, I., Gutiérrez-Soto, B., Navarro‐Marí, J. M., & Fernández, J. G. (2023) · Revista Española de Quimioterapia · doi:10.37201/req/099.2022 · Cited by 15
Metadata
- Authors
- Rees, J., Abrahams, M., Doble, A., Cooper, A., & the Prostatitis Expert Reference Group (PERG)
- Affiliations
- Backwell and Nailsea Medical Group Bristol UK
- Addenbrooke's Hospital (GB)
- Prostate Cancer UK (GB)
- Corresponding author
- Rees, Jon
- Venue
- BJU International
- Publisher
- Wiley
- Published
- 2015-06-16
- Volume
- 116
- Issue
- 4
- Pages
- 509-525
- ISSN
- 1464-4096 (ISSN-L)
- 1464-410X
- PMC
- PMC5008168
- OpenAlex
- W1997393900
- Semantic Scholar
- 09427e0cfa20489b48a373972c9f66172cfd9cf1
- Cited by
- 371
- References
- 113
- Citations by year
- 2026: 35 · 2025: 34 · 2024: 50 · 2023: 50 · 2022: 32 · 2021: 35 · 2020: 28 · 2019: 31 · 2018: 31 · 2017: 20 · 2016: 18 · 2015: 7
- FWCI
- 21.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- British Journal of Urology (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- Funders
- Prostate Cancer UK
- Topics
- Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
- Health Sciences › Medicine › Urology › Urinary Tract Infections Management
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Keywords
- chronic bacterial prostatitis, chronic prostatitis/chronic pelvic pain syndrome, diagnosis, treatment, multidisciplinary team, lower urinary tract symptoms, urogenital pain, sexual dysfunction, neuropathic pain, alpha-blockers, antibiotics, quinolones, patient information, specialist referral
- MeSH terms
- Humans, Male, Prostatitis, Pelvic Pain, Consensus, Chronic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.